GAL-3 Genetic Screening

Unlock insights that help guide your approach to dementia-related treatments. Check your LGALS3 gene and see if TB006 therapy may be right for you.

Results in 10-14 Business Days

Why It Matters

Get Answers That Help You Plan your Next Step

Your LGALS3 gene affects how your body regulates galectin-3, a protein linked to inflammation and cognitive decline. This test gives you insight you can use as you explore TB006 and other care options.

How It Works

Three Steps to Clear Genetic Insight

Create Your Account

A simple signup gives you access to the portal.

Link Your Kit

Scan or enter the barcode from your kit.

Swab and Send

Collect your sample and mail it back in the prepaid envelope.

Results in 10–14 business days

What You Receive

Everything You Need
in One Kit

Your kit includes a swab, return packaging, and a priority mailer. Your digital report explains your gene profile in simple, clear language.

Why People Choose Us

A Secure and Trusted Testing Process

Your data stays encrypted and under your control. Every sample is processed under strict lab standards, giving you confidence in the results.

The Science Behind the Test

Understand How Your Biology May Shape Your Options

LGALS3 helps regulate Galectin-3, a marker tied to inflammation and cognitive health. Knowing your profile can guide conversations about TB006 with your provider.

Your Results

Clear, Actionable Insights

Your digital report breaks down your LGALS3 activity, explains what it means, and gives you guidance for next steps you can share with your care team.

FAQ

Common Questions

What is the GAL-3 Function DNA Report?

The GAL-3 Function DNA Report is a simple, non-invasive genetic test that analyzes a patient’s DNA using a cheek swab. It focuses on variations in the LGALS3 gene, which regulates Galectin-3, a protein associated with inflammation, neurodegeneration, and cognitive decline—including dementia-related conditions.

This test helps determine whether your patient carries a specific genetic profile that blocks TB006—a monoclonal antibody therapy—rendering it ineffective in approximately 1 out of every 25 treated patients. Identifying this profile in advance allows for more informed treatment decisions and personalized care strategies.
This is a Research Use Only (RUO) genetic report and is not intended to diagnose disease. It offers predictive insights based on known gene-environmental interactions and current literature, which can be used to inform clinical decision-making.
The test uses a non-invasive cheek swab, which can be completed in minutes in-office or at home with clear instructions provided.
Once the sample reaches our certified lab, results typically take 10–14 business days.
Test results are delivered securely through the provider portal or email. You will receive a notification once your patient’s report is ready to view and download.

Visit tb006test.com/registerpatient and follow the prompts to securely register your patient and assign their sample kit using the barcode provided.

Use this link to order additional collection kits. These are collection kits only. You will only pay the lab fee when you later order the actual test.

Yes. You will need the barcode or kit ID provided with the DNA swab kit. This links the patient to their unique test and enables proper lab processing.
Yes. All data is protected with advanced encryption and complies with HIPAA and CLIA standards. No data is shared or sold without explicit consent.

Absolutely. Patients can request full deletion of their personal and genetic information at any time by contacting support@endodna.com.

Take the First Step Toward Clarity

Get genetic insight that supports more informed decisions about TB006 and cognitive health.

Results in 10–14 business days